Skip to content

Gut microbiota based clinical study of portal vein thrombosis after transjugular intrahepatic portosystemic shunt in liver cirrhosis

Clinical studies of alternations of human internal environment and risk prediction of adverse events subsequent to transjugular intrahepatic portosystemic shunt in liver cirrhosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000039673
Enrollment
Unknown
Registered
2020-11-05
Start date
2020-11-09
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

Healthy control:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18 to 75 years; 2) Diagnosed with liver cirrhosis; 3) Receive elective TIPS.

Exclusion criteria

Exclusion criteria: 1) Previous treatments with TIPS or surgical shunt; 2) Presence of portal vein thrombosis before enrollment; 3) Consumption of anticoagulant or antiplatelet medications; 4) Thrombophilia; 5) Prescribed with medical enternal or parenternal nutrition, antibiotics, or lactulose within 4 weeks before enrollment; 6) Gastrointestinal bleeding, spontaneous bacterial peritonitis, hepatorenal syndrome, or hepatopulmonary syndrome is uncontrolled or stable less than 1 week; 7) Vital organ insufficiency (heart, lung, kidney, brain, etc.); 8) Residency in high altitudes (higher than 2500 meters above the sea level); 9) In pregnancy or lactation; 10) Child-Pugh score exceeds 12 points or aminotransferase elevation exceeds five times of upper limits of normal; 11) Cholestatic diseases (primary biliary cirrhosis, primary sclerosing cholangitis, extrahepatic bile duct obstruction etc.); 12) Presence of malignancy; 13) Portal cavernoma.

Design outcomes

Primary

MeasureTime frame
Gut microbiota;PVT;

Countries

China

Contacts

Public ContactHao Wu

West China Hospital, Sichuan University

594264513@qq.com+86 28 85423387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026